Journal of Vascular Surgery® is dedicated to the science and art of vascular surgery and aims
to improve the management of patients with vascular diseases by publishing relevant papers that report important medical advances, test new hypotheses, and
address current controversies. To achieve this goal, the Journal will publish original clinical and laboratory studies, and reports and papers that comment
on the social, economic, ethical, legal, and political factors, which relate to these aims. As the official publication of The Society for Vascular Surgery,
the Journal will publish, after careful peer review, selected papers presented at the annual meeting of this organization and affiliated vascular societies,
as well as original articles from members and nonmembers.
Journal of Vascular Surgery: Venous and Lymphatic Disorders publishes high quality clinical, research, case
reports, techniques, and practice manuscripts related to all aspects of venous disease, lymphatic disease, and
wound care with an emphasis on the practicing clinician. The journal seeks to provide novel and timely
information to vascular surgeons, interventionalists, phlebologists, wound care specialists, and allied health
professionals who treat patients presenting with vascular and lymphatic disease.
The following Instructions for Authors apply to both Journal of Vascular Surgery and Journal of Vascular Surgery: Venous and Lymphatic submissions. Submitted manuscripts will be considered for publication in both Journals. If your manuscript is selected for publication in the Journal of Vascular Surgery: Venous and Lymphatic Disorders you will be charged a fee for the color images included in your paper. The publisher will collect this fee, which will be $650.00 for the first color image and $150.00 for each additional color image. Unless your figures are sufficiently complex to merit color, please submit charts and graphs in black and white.
Originality of manuscript
Editorial Policies and Information for Authors are printed in the January, March, July, and September issues, are available on the Journal web site (http://journals.elsevierhealth.com/periodicals/ymva) and the Editorial Manager web site (https://www.editorialmanager.com/jvs/account/AuthorInstructions.pdf), and may be requested from the Editors.
The authors must certify that their article is original, has been written by the stated authors, has not been published previously, and is not under consideration for publication by another journal. These and other warranties are attested to at the time of submission and when the Copyright Transfer form is signed.
Previous presentations and abstracts. If the work has been presented previously at a meeting as an oral presentation or poster or has been published in an abstract, a detailed report will be considered for publication. However, the authors are expected to submit the details of the previous presentations and provide the abstracts. In general, manuscripts will not be considered if the work had been published previously in full-length conference proceedings or as a book chapter.
Major update of a previous study. If the submitted manuscript is a major update of the results of a previously published study, the authors must submit copies of the previous papers so that the Editors can determine whether the new paper provides significant new information or statistical power to warrant publication. In general, such updates should increase the number of patients by at least 50% or the reported mean follow up by at least 2 years.
Media releases. The Editors recognize that news organizations have the right to disseminate information that may have been obtained from a presentation at a scientific meeting or through direct discussions with the author. It is the author's responsibility to inform the Editors that the work has been reported previously by a journalist and explain the circumstances. In doing so, the authors should supply the Editors with the original media report. If the results of the study may potentially have a major impact on patient management, the authors can request the Editor's consideration of prompt review and publication. Once submitted to the Journal, discussion of the contents of a manuscript with the media must be delayed until the review process is complete and the manuscript is posted at the Journal's web site pending publication, unless the Editors provide prior approval. If the authors provide additional information to the media during the peer-review process, the article may be rejected or withdrawn from publication. In some instances, the Editors may ask the authors to prepare a brief press release summarizing the manuscript. However, as with all papers, further discussion of the results with the media must be deferred until the acceptance and postings of the manuscript.
Multiple publication. A joint publication or secondary publication of a full-length paper in another journal may be considered if the manuscript contains important information that deserves to be disseminated to a significantly different readership than that of the Journal. The Editors of the Journal may grant permission for secondary publication in another journal if the original report in the Journal is appropriately acknowledged and the secondary publication follows the initial publication in the Journal. Abstracts or full-length summaries of papers presented at meetings may be published simultaneously in another journal with permission of the Editors of both journals providing an appropriate acknowledgment is made in each journal.
To qualify for authorship in the Journal of Vascular Surgery, each author must have made a significant contribution to the conception or completion of the manuscript and is willing to share the responsibility for the content of the paper. Specifically, each of the authors should have made a direct and substantial contribution to the following areas:
These guidelines are based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (available at: http://www.icmje.org). Each of the authors will be expected to read the Author Role, Originality and Competition of Interest form submitted by the corresponding author. By signing the Copyright Transfer form once the paper is accepted, the corresponding author attests to the accuracy of the Author Role, Originality, and Competition of Interest form.
Number of Authors. Generally, the maximum number of expected authors for a clinical or basic research manuscript is eight. See the table in the "Requirements for Specific Submission Types" section for more information. The Editors request that additional authors be carefully examined with respect to the authorship criteria listed above, and suggest that some might better be acknowledged than listed as authors. Further, the Editors request that authors beyond this expected number be specifically justified in the "author comments" section of the electronic submission. In special circumstances (e.g., multi-center trials, complex randomized trials or reports involving complex testing by multiple departments), the Editors will consider as many as ten authors for clinical or basic research papers, and eight for case reports and technical notes, but this is the absolute maximum. As an alternative, a smaller number of key authors can submit the work on behalf of a larger research group, which can then be listed and acknowledged in an appendix. If an author has collaborated in a project but does not meet all the requirements for authorship, he or she should be recognized in the acknowledgment section of the manuscript. The Journal publishes an Author Contribution Statement at the end of each Clinical and Basic Research manuscript. The information for this statement should first be submitted as part of the Author Role form upon submission and attested to by a completed Author Contribution Statement form at the time of acceptance. The order of the authors' names is at the discretion of the coauthors who may wish to add a footnote explaining the order of authorship and/or author contributions. If two authors participated equally and would qualify for "first authorship", this can be indicated on the author role form and will be published in a footnote to the article. Additional explanation of these policies is reproduced below from "Criteria for authorship". J Vasc Surg 2005; 42-599.
The authors' university, institutional, and/or corporate affiliations must be acknowledged on the title page along with sources of funding. In addition, the Journal expects the authors to disclose any commercial associations that might represent a competition of interest in respect to the manuscript. If a company's product is mentioned in a manuscript or other article type (including Letters to the Editor and Editorials), all authors are expected to declare whether they have a consulting or employment arrangement or a royalty or stock agreement with the company. The authors must indicate any competition of interest or the lack thereof on the Author Role, Originality, and Competition of Interest form that is required before a manuscript can be sent out for review. During the review process, this relationship will be held in confidence.
A competition of interest statement is published with each paper: see Johnston KW Rutherford RB. Disclosure of competition of interest. J Vasc Surg 1999; 30:200-2. If a paper is accepted for publication, the authors will be asked to clarify and update their competitive interest statements.
Failure to disclose a competition of interest will be dealt with according to the following article paragraph, which was published in the Journal: see Johnston KW, Rutherford RB. Failure to disclose competitive interest. J Vasc Surg 2000; 31:1306:
"If it is brought to the Editors' attention that an author may have failed to make an appropriate disclosure, the Editors will give the author the opportunity to explain. If a satisfactory explanation is not forthcoming, the Editors will bring the issue to the attention of the author's institution for clarification. If the oversight can be explained as an honest mistake, a simple notation of the error will be published. If there was either self deception or a deliberate attempt to conceal a significant financial competitive interest, the Editors will conclude that this may represent an attempt to deceive and may be a violation of public and professional trust. The Editors may publish a notation that the paper may be unreliable because the author did not meet the standards of honest disclosure of competitive interests required by the Journal."
Manuscripts that involve research conducted on human subjects must follow the principles outlined in the Declaration of Helsinki
(http://www.wma.net/en/30publications/10policies/b3) and include a statement in the Methods section stating that the experimental protocol and informed consent were
approved by the Institutional Review Board, and that all subjects gave informed consent. Manuscripts that report animal experiments must include a statement
in the Methods section stating that the study was approved by the Institutional Review Board and that the animal care complied with the Guide for the Care
and Use of Laboratory Animals, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Washington: National
Academy Press, 1996 (http://nap.edu/openbook.php?record_id=5140).
IRB FAQs from the FDA: http://www.fda.gov/regulatoryinformation/guidances/ucm126420.htm.
In 2004, the International Committee of Medical Journal Editors (ICMJE) recommended that clinical trials be registered in a public database as a prerequisite for subsequent publication:
See De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004; 351:1250-1.
Per the policies recommended by the ICMJE, the Journal of Vascular Surgery requires the pre-registration of all prospective clinical trials that have a control group:
See Cronenwett J, Seeger J. Requirement for Registration of Clinical Trials. J Vasc Surg 2007;45:1.
In addition, the Journal also requires the pre-registration of any commercially-sponsored clinical trial, including Phase I and II trials. We do not anticipate registration of retrospective reviews or summaries of standard clinical treatment. Clinical trials that meet the above requirement and commenced after July 1, 2007 must be registered prior to enrollment of the first patient. Relevant trials that began before this date must be registered prior to editorial review. Registration must be indicated by providing the unique study number assigned at www.clinicaltrials.com, the principle site of registration sponsored by the National Library of Medicine (NLM). Detailed directions and a tutorial for registering a trial are available at http://prsinfo.clinicaltrials.gov. Authors of unregistered trials, or those with inadequate information in the registry, will be given an opportunity convince the Editors that their rationale for omitting this was critical, but it is the Journal's expectation that clinical trials involving prospective comparison of treatment or any that are commercially sponsored have been registered after July 1, 2007.
Manuscripts become the property of the Journal for which they are accepted, both of which are copyrighted by The Society for Vascular Surgery. They may not be published or reproduced in whole or in part without the written permission of the author(s) and the Publisher. The Journal's requirements for submission of a manuscript are in accordance with "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication" of the International Committee of Medical Journal Editors (ICMJE), published in JAMA 1997; 227:927-34, and available at http://www.icmje.org/index.html. This article is not covered by copyright and can be reproduced and distributed if such use is not for profit.
Permission to reproduce published material. Permission to reproduce material published in the Journal of Vascular Surgery and Journal of Vascular Surgery: Venous and Lymphatic Disorders must be obtained from the Publisher at (215) 239-3804 or online athttp://journals.elsevierhealth.com/periodicals/ymva/content/permission. Authors will be consulted, whenever possible, regarding reproduction or republication of their material.
Editors' and Publisher's waiver of responsibility. Statements and opinions expressed in articles and communications herein are those of the author(s) and not necessarily those of the Editors and Publisher. The Editors and Publisher disclaim any responsibility or liability for such material. Neither the Editors nor the Publisher guarantee, warrant, or endorse any product or service advertised in the Journal, and they do not warrant any claim made by the manufacturer of such product or service.
Using Our Online Submission Software. All new and revised manuscript files, required forms, and associated content must be submitted electronically through Editorial Manager software (online at: http://www.editorialmanager.com/jvs/default.asp). Authors must be registered on the Editorial Manager web site. Use of Editorial Manager to upload submissions requires an internet connection, a valid email address, Adobe Acrobat Reader (free download at http://www.adobe.com//products/acrobat/readstep2.htm, and Microsoft Word 2003 or 2007. Complete submission instructions are provided on the Editorial Manager web site. Please note that all original and revised submissions formats and inclusions must be in accordance with the Information for Authors. Manuscripts that do not meet all submission requirements will be returned to the author for correction.
To upload a manuscript using Editorial Manager, authors must provide the following information during the submission process:
This information is provided to reviewers and Editors for their evaluation of appropriate involvement. A Competition of Interest Statement will be published with each manuscript based on the information provided on this form.
The Journal requires that authors specify their roles and meet the requirements for authorship, as listed in the Uniform Requirements
for a Manuscript Submitted to Biomedical Journals. These requirements state that each author must contribute to a manuscript in each of the
following three areas:
This statement will be reproduced at the end of your manuscript in the printed and online journal, just prior to the reference section.
This form is required if your manuscript includes data which might reveal the identity of one of more patients.
The following checklists are available for download and are intended to assist authors with the submission process. Use of these forms will help to insure that submissions are complete.
Authors of new submissions may wish to download the New Submission Checklist to help insure completeness of submission files. Please do not upload this form into Editorial Manager.
Authors of revisions may wish to download the Revised Submission checklist to help insure completeness of revised submission files. Please do not upload this form into Editorial Manager.
Text formatting instructions. All text files must be prepared using: Microsoft Word, double spaced with Times New Roman 12-point font, pages numbered consecutively in the upper right-hand corner of the text file, line numbers to the left of the text, and 1-inch margins on all pages. Manuscripts must conform to standard English usage and are subject to editing in conformance with the policies of the Journal. For reference, authors may consult the American Medical Association's Manual of Style (AMA Manual of Style: A Guide for Authors and Editors. Iverson C, Christiansen S, Flanagin A, et al. 10th ed. New York: Oxford University Press, 2007) (AMA-10). The following changes have been made from the 9th edition of the AMA Manual of Style.
Elsevier Language Services: http://webshop.elsevier.com/languageservices/
Generic drug names from the United States Adopted Name (USAN) should be used. Proprietary drug names may be cited in parentheses. Generic equipment names should be used whenever possible, and the proprietary name of the equipment must be cited in parentheses after the proprietary name. Cite the manufacturer and the city, state, and country of manufacture. Measurements of height and weight, etc., should be stated in metric units. Hematologic and clinical chemistry measurements can be stated in System International (SI) units or non-SI units. Note that SI units are recommended in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication" ( http://www.icmje.org/index.html). Only standard abbreviations should be used; avoid unusual or coined abbreviations. The first time any abbreviation is used it should be included in parentheses after the words it replaces. Abbreviations should not be used in the title or abstract.
Manuscripts should conform to the guidelines for reporting on vascular surgery. The following have been developed by the Ad Hoc Committee on Reporting Standards and accepted by The Society for Vascular Surgery:
Title/Title page. Titles must be concise and accurately reflect the content of the manuscript. Furthermore, titles should be declarative, stating the topic and results when possible, rather than posing a question. This is important for assisting clinicians and researchers in locating an article on Medline once it has been published. Please make sure that your title:
A complete title page is required for all submissions. The title page must include:
Abstract. A structured abstract is required for all manuscripts except case reports and technical notes (both of which require a shorter,
non-structured abstract), vascular images, special articles, editorials, and presidential addresses. The abstract must be uploaded into Editorial Manager
as a separate file from the rest of the manuscript and must include the title of the manuscript, the names of authors, affiliations, and contact information
for the Corresponding Author. The abstract replaces the summary and ordinarily should clearly state, in approximately 250 words (but never more than 400
words), the main factual points of the article. The abstract should be informative, not descriptive. Detailed results should be included in the abstract
because many readers only have access to abstracts and not the entire article. A structured abstract will include combinations of the following headings
that apply and are informative, as described in detail in previous publications:
Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardiner MJ. More informative abstracts revisited. Ann Intern Med 1990;113:69-76
Ad Hoc Working Group for Critical Appraisal of the Medical Literature. A proposal for more informative abstracts of clinical articles. Ann Intern Med 1987;106:598-604
Typical abstract headings include:
For brevity, phrases rather than complete sentences can be used in some sections. Tables, figures, reference citations, and trademarked names should not appear in the abstract. Because many readers only have access to the abstract, it is essential that it contain numerical results and not simply summary conclusions.
The manuscript, including the abstract, must be uploaded as a separate file. The usual sections for a full basic or clinical science manuscript include Introduction, Methods, Results, and Discussion. Subheadings may be useful and help clarify the content in longer papers. Methods must be described in sufficient detail to allow others to reproduce the work. For established methods, appropriate references and a brief description are sufficient; but for new methods, appropriate details are required. If the description of the method is very long, the techniques should be summarized and referenced and the details provided as an appendix that will be published on the internet but not in print. For human studies, the following details are generally important: eligibility (inclusion and exclusion criteria), randomization methods, blinding methods, total consecutive patients enrolled, and number of exclusions or drop outs and reasons. For randomized controlled trials, the CONSORT document provides reporting guidelines that should be met in articles submitted to the Journal:
See Moher D, Schultz ICF, Altman DG for the CONSORT group. The CONSORT statement: revised recommendation improving the quality of reports of parallel group randomised trials. Lancet 2001;357:1191-4. Full details are available at http://www.consortstatement.org/. This article provides a checklist of the items that should be included in the report of the methods, results and discussion and the suggested details of a flow diagram that provides information on patient flow through the study. Observational studies should include these details as well.
Standards have been published that provide guidelines for reporting meta-analyses of the randomized controlled studies: See Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUORUM statement. Lancet 1999;354:1896-900.
Reporting standards have been published that provide guidelines for observational studies: See Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis of Observational Studies in Epidemiology [MOOSE] group. JAMA 2000;283:2008-12.
A redline manuscript is required for all revised submissions and must meet all of the formatting requirements of the non-redlined manuscript. The redline manuscript must be created using "Track Changes" in Microsoft word, and must show every change that has been made in the revision. Manually highlighting, underlining or otherwise indicating the changes made is not sufficient. Detailed instructions about how to create a redline document may be found here.
Limit illustrations to those that amplify, and do not duplicate the text. A reasonable number of line or halftone illustrations will be reproduced. You may not submit more than the maximum number of figures permitted for the selected article type. Please review the instructions for the specific article type before proceeding. Inclusion of color illustrations is at the discretion of the Editor. Operative and pathology photographs should be in color. Other figures and charts should be black and white unless sufficiently complex to require color. Original drawings or graphs should be prepared by computer software or by a professional artist.
All images must be submitted electronically via the Editorial Manager system as separate numbered files. Number your figures consecutively in Arabic numerals according to the order of citation in the text. All figures must be cited. This includes images that are intended to be “online only” appendices. (Example: Figure 1A, Figure 1B, Figure 2, Supplemental Figure 1, Supplemental Figure 2). TIFF, JPEG, and EPS files must have a resolution of at least 300 DPI at 3 inches wide. Microsoft Word and PowerPoint files are acceptable, as long as the illustration spans at least 3inches in the document, the image is sharp, and all text is legible. Lettering or text used in the illustration must be at least 8-point font. Submissions that include figures that are embedded in the text of the manuscript, or that include figures that are compiled in one file, will be returned to you for correction. During the submission process, illustrations will undergo an Artwork Quality Check which will not function properly unless the images are uploaded as separate files.
When you submit files, please pay attention to the results of the Artwork Quality Check. If the results of the check indicate "pass", your image files are acceptable. If your results are "pass with warning", this does not necessarily mean that your figures are acceptable. To determine whether or not your illustrations will be acceptable for publication, note the number located in the top right-hand corner of the Artwork Quality Check results page. The resolution of each figure will be calculated at a size of 18 picas (3 inches) wide. If the resolution is 300 DPI or greater at a size of 18 picas (3 inches), it is appropriate for submission. Images that are less than 300 DPI at a width of 18 picas are unacceptable. You must correct your figures before proceeding. If you fail to improve the figure quality and you submit your manuscript, the submission will be returned for correction. For assistance, contact the Editorial Office at: email@example.com.
Elsevier Illustration Services: http://webshop.elsevier.com/illustrationservices/index.cfm
Previously published images. If a figure has been previously published, the legend must give full credit to the original source, and a letter from the original source giving permission to reproduce the figure must be uploaded with the submission. Submissions with previously published images that are not accompanied by an original written permission document will be returned to the author.
Life table graphs. Lines should be truncated when the standard error exceeds 10% and should have the "n" for each group at relevant time points along the x-axis. Because life table graphs are preferred for in-text inclusion, data tables should be submitted only for the online version of the manuscript if the authors desire to provide this level of detail.
Legends must be numbered, double spaced and uploaded in a separate document file. Indicate original magnification and stain for photomicrographs.
If accepted, videos will be published on the Journal Web site. Videos must be uploaded in either a QuickTime or MPEG format. Authors who want their videos accessible in a streaming format must also provide either a single SureStream file or three uniquely named single-rate clips (28.8, 56, T1) with an SMIL file to list the bandwidth choices. Video clips must meet production quality standards to be published on the web without modifications or editing by the editorial office. The Journal can accept only video submissions that meet the Journal's formatting and image quality requirements. Authors will be notified if there are any problems with submitted files and asked to resubmit modified files. Image editing and correct formatting are the author's responsibility. Video clips accepted for publication will be posted to the Journal's Web site in both non-streaming format such as QuickTime and MPEG for optimal image quality and in a streaming video format for those who prefer faster downloading.
Tables should supplement, not duplicate, the text. Results should not be summarized in a table; use a graph instead. Number your tables consecutively in Roman numerals according to the order of citation in the text. All tables must be cited, including tables intended to be supplemental “online only”. Example: (Table I, Table II, Supplemental Table I, Supplemental Table II.) Because tables should be self-explanatory, provide a brief caption for each table. Tables must be created in a Microsoft Word using 12 pt. Times New Roman font. Double space your tables and upload them to Editorial Manager. Tables may be uploaded together in one Word document, with each table starting on a new page, or in separate files. They may not be embedded in manuscript document. Manuscripts with tables that do not meet these requirements will be returned to the author.
Abbreviations used in the table should be explained in a footnote; however, abbreviations that have been defined in the body of the text do not need to be spelled out or explained in the table. If a table or any data therein have been previously published, a footnote in the table must give full credit to the original source, and the original Publisher's permission to reproduce the table must be provided.
Cite references selectively (using no more than 40); an extensive literature review is rarely necessary and only pertinent references should be given, (i.e., those that provide the basis for a key statement). References should be cited consecutively in the text by superscript Arabic numbers in the order in which they are first mentioned in the text, a table, or a figure. References should not be cited alphabetically. The reference list should be double spaced. References to articles in press must include authors' names, title of article, and name of journal. Personal communications and unpublished data are not to be cited as references; instead, indicate these sources in the text at the appropriate place and include the individual's preferred given name, initials, surname, title, city, and year of communication. A note of approval from the source for the statement should be appended to the manuscript. Make sure all references have been verified. The accuracy of the references, including spelling of references in foreign languages, is the responsibility of the authors and is crucial so that they can be linked to the original citation in the web version. Authors should be certain that all references use the standard abbreviated journal names according to Index Medicus. This is imperative to ensure linking of references in the online version of the Journal. References that do not use the standard abbreviated journal names will not link. If there are six or fewer authors, list all; if seven or more, list only the first six, then et al. The format for references is described in detail in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication" (http://www.icmje.org/index.html). Examples follow:
During the submission process, authors whose papers have been presented at a sponsoring society meeting must choose their sponsoring society and year of presentation from the available drop-down menu. An option of 'none" may be chosen by those authors whose submissions are not affiliated with a sponsoring society.
For manuscripts that contain statistically-analyzed data, the corresponding author must identify the co-authors or consultants responsible for the statistical analysis on the Author Role form.
Special care must be taken to exclude photographs/images that contain identifiable individual characteristics such as eyes, case numbers, initials, etc. Photographs of identifiable individuals must be accompanied by a Patient/Volunteer Consent form. This form must bear the signature of identifiable patients/volunteers. In cases where the patient/volunteer is a minor or incapable of signing the consent form, the signature of both living parents or guardians is required. This form must be uploaded at the time of submission of a new manuscript. Alternately, photographs can be masked with black boxes that cover identifiable individual characteristics.
Basic Research Articles do not include human clinical information but may include those studies in which only group samples of human blood or tissue are used and the results/conclusions are research oriented.
Clinical Research articles involve human clinical information, descriptions of patient populations, and clinical applicability
Case Reports. A Case Report will be only be considered for publication if it describes a new disease, important original observation, or a unique technical approach and succinctly reviews the relevant literature. Case Reports should not exceed 1200 words, three figures, and 20 references, with an overall limit of 12 typewritten double-spaced pages with 12-point font and 1-inch margins. A brief 100-word non-structured abstract, uploaded as a separate file, should emphasize the important message illustrated by the case(s).
Vascular Images.Submissions accepted for the Vascular Images Section present interesting vascular images and associated short educational summaries in a focused, case-report format. Up to three manuscripts may be published in each issue, and one image will be selected for the cover. When submitting this type of manuscript, please make sure that you have designated which image should appear on the Journal cover. The Editor may not select an image from your accepted manuscript for the cover; however, it is required that you designate one image as the cover image before submission. Previously, published images will not be considered for this section. Color illustrations that are suitable for the Journal cover are preferred. Cover images must not include arrows, or any other added graphics and, whenever possible, text should be cropped out of the cover image. Appropriate images include radiographs, pathology, anatomy, operative findings, and other relevant clinical pictures. The images should illustrate features of vascular disease, including technical approaches. Illustrations and text must be confined to one printed page (no more than 350 words, with a limit of four illustrations: one for the cover and three that must fit in the right hand column). The Vascular images should possess both scientific and artistic merit. Descriptions of images must be included in the text, and only key references should be provided (with a limit of two). Images must be of professional quality and meet the basic requirements for resolution specified in Illustrations (figures, charts, graphs).
Letters to the Editor/Responses. A letter containing 500 words or less, with no more than six references and one illustration or table, will be considered for publication if it amplifies a recent article in the Journal by extending or clarifying the original manuscript content, or by presenting an opposing interpretation of the results or conclusions. Letters may also be used to submit brief original observations or opinions. The authors of the original paper will be provided with an opportunity to respond to a Letter to the Editor. If the authors respond in a timely fashion, both the Letter to the Editor and the authors' Response will be published together. Letters accepted for publication may be copyedited. Titles for Letters to the Editor and Responses must include the original referring manuscript number.
Invited "Special Sections" Submissions. Although manuscripts for these "Special Sections" will generally be invited from specific authors, unsolicited submissions could be considered. Authors of unsolicited manuscripts should contact the Journal office to discuss their potential topic with the Assistant Editor prior to submission.
The Publisher will edit and send out Author Proofs only to corresponding authors. Corrections to these proofs must be returned to the Publisher within 1 week. The Publisher is responsible for sending and receiving Copyright Transfer Forms. Any delay in return of page proofs and Copyright Transfer Forms to the Publisher will result in a both a delay of article placement on the JVS web site In-Press section and in print publication. Please do not send completed Copyright Transfer Forms to the Editorial Office.
The Publisher is responsible for the printing and mailing of requested Reprints. As a courtesy, the Publisher will send 25 free Reprints to the corresponding author. Any Reprints in excess of this number must be requested from the Publisher when the Copyright Transfer Form is returned.